Xerox Holdings Corp. (0A6Y)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 2.585 |
|---|---|
| 52-week range | 1.199 – 3.771 |
| Return, 1 month / 3 months | −23.2% / −6.0% |
| Return, 1 year / 3 years | −27.7% / −75.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 80.5% |
| Worst drawdown (1 year) | -64.8% |
| Average daily value traded | 0.03M USD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Xerox Holdings Corp. is an American company that makes printers, copiers and multifunction devices for offices and other organisations. It also supplies related consumables such as toner and offers document management and printing services. Its customers include businesses, government bodies and other institutions that handle large volumes of documents. The company is based in Norwalk, Connecticut, in the United States.
Xerox Holdings Corp. trades under the code 0A6Y on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Xerox Holdings Corp. (0A6Y) trades on the London Stock Exchange in UK. It last closed at USD 2.585 on 27 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,764 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 27.7% and over the last three months it fell 6.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.4% | ||
| From 52-week high | -28.4% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.0% | ||
| 6-month return | 62.6% | ||
| 12-month return, skipping the last month | -5.8% | ||
| Stability (higher is calmer) | 10 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 80.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -64.8% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | −23.2% |
| 3 months | −6.0% |
| 6 months | +62.6% |
| 1 year | −27.7% |
| 3 years | −75.5% |
| 5 years | −81.1% |
Signals
| 50-day / 200-day average | 3.038 / 2.550 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.176 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Dec 2025 | USD 0.0250 |
| 30 Sep 2025 | USD 0.0250 |
| 27 Jun 2025 | USD 0.0250 |
| 31 Mar 2025 | USD 0.1250 |
| 30 Dec 2024 | USD 0.2500 |
| 30 Sep 2024 | USD 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.